Cisplatin 1 mg/mL (Cisplatin INJECTION) 1 mg/mL

Cisplatin 1 mg/mL is an injectable medication used for various therapeutic purposes. This intravenous solution is manufactured by Accord Healthcare Inc. and is available in 50 mL vials.

Strength

1 mg/mL

Pack Size

50 mL in 1 VIAL (16729-288-11)

Manufacturer / TM Owner

Accord Healthcare Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cisplatin 1 mg/mL is commonly used in medical settings for its cytotoxic properties. It is often administered intravenously to target rapidly dividing cells, making it a key component in certain treatment protocols. Patients and healthcare providers frequently search for 'what is Cisplatin used for' to understand its role in medical therapies.

Side Effects

Cisplatin 1 mg/mL may cause various effects, including nausea, vomiting, and fatigue. Some individuals might experience changes in kidney function or hearing. These effects can vary widely among patients, and it is important to monitor for any adverse reactions.

Precautions & Warnings

Handling Cisplatin 1 mg/mL requires careful attention to safety protocols. It should be administered by healthcare professionals in a controlled environment. Patients should be monitored for any signs of allergic reactions or other adverse effects. Proper disposal of used vials is essential to prevent environmental contamination.

Avoid Interactions

Cisplatin 1 mg/mL may interact with other medications, including those that affect kidney function or hearing. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements may also influence the effects of Cisplatin.

Frequently Asked Questions

Cisplatin 1 mg/mL is used in medical settings for its cytotoxic properties, often targeting rapidly dividing cells.

Cisplatin 1 mg/mL is administered intravenously by healthcare professionals in a controlled environment.

Common effects may include nausea, vomiting, fatigue, and changes in kidney function or hearing.

Yes, it should be handled and administered by healthcare professionals, and patients should be monitored for adverse reactions.

Yes, it may interact with medications affecting kidney function or hearing, so inform healthcare providers about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.